Cornuside ameliorated experimental autoimmune encephalomyelitis by limiting the recruitment of CD4+ T lymphocytes in the spinal cord. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 58, 2022. DOI: 10.1590/s2175-97902022e191070 . Disponível em: https://periodicos.usp.br/bjps/article/view/203994.. Acesso em: 10 jun. 2024.